The Bioproduction Congress is the annual event of the biopharmaceutical production sector where stakeholders from Europe gather together to showcase and exchange the latest innovations in bioprocessing. This dynamic event promotes exchanges on the future of biomanufacturing, addresses the current challenges and showcases the new breakthrough solutions.

This year’s event in Lyon brings together experts from companies (big pharmas, SME and start-ups) and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.

Catch up with our colleague Thomas Martens (BD & Sales Manager) and be sure to check out Koen Sandra‘s (CEO) presentation on the fully automated assessment of multiple attributes of monoclonal antibodies.